# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Predictive Oncology Inc. (NASDAQ:POAI), a leader in AI-driven drug discovery and biologics, announces a collaboration with FluG...
Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(0.85) per share. This is a 57.5 percent increase over losses o...